Clinical Trials Directory

Trials / Completed

CompletedNCT01501786

Does Ketamine Attenuate Depression of Respiratory and Cardiac Functions

The Effect of Small-dose Ketamine on Depression of Respiratory and Cardiac Functions Caused by Propofol in Pediatric Cardiac Catheterization

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
150 (actual)
Sponsor
Ibaraki Children's Hospital · Academic / Other
Sex
All
Age
6 Months – 10 Years
Healthy volunteers
Not accepted

Summary

Normal cardiac and respiratory functions should be maintained during pediatric cardiac catheterization. Propofol has become a popular choice for sedation in children, however, it depresses cardiac and respiratory functions. Some investigators reported that ketamine attenuates its depressant effect, but it remains unclear whether ketamine reduces cardiac and respiratory depression caused by propofol in pediatric cardiac catheterization.

Conditions

Interventions

TypeNameDescription
DRUGcontrolpropofol 8mg/kg/h saline 0.24 ml/kg/h
DRUGKet10propofol 6.4 mg/kg/h ketamine 10 microg/kg/min
DRUGKet20propofol 4.8 mg/kg/h ketamine 20 microg/kg/min

Timeline

Start date
2012-01-01
Primary completion
2013-05-01
Completion
2013-05-01
First posted
2011-12-29
Last updated
2013-07-30

Locations

1 site across 1 country: Japan

Source: ClinicalTrials.gov record NCT01501786. Inclusion in this directory is not an endorsement.